Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Creating a Success of ePedigree and RFID in Pharma (Strategic Focus)

Published by: Datamonitor

Published: Jun. 30, 2008 - 32 Pages


Table of Contents


Overview
Catalyst
Summary
Key Messages
Counterfeiting is an increasing problem for the pharmaceutical industry
Legislation could be key to the success of ePedigree and RFID
Implementations of ePedigree and RFID will not be simple
Geographic differences add an extra layer of complexity
Table of Contents
Table of figures
Market Opportunity
RFID can help solve many of pharma's pain points
RFID is a solution that is becoming more advanced and cost effective
ePedigree is a critical technology for the development of anti-counterfeiting measures in pharma
Understanding the difference between ePedigree and serialization
Pharma companies often choose 2D barcodes over RFID
The need for RFID is being driven from multiple directions but legislation is primary
The prevalence of counterfeiting is driving the need for RFID
The sale of drugs through the internet has proved a problem for preventing the spread of counterfeit drugs
The increase of legislation will help to drive the uptake of RFID
Uncertainty around legislation makes the market a challenging environment
RFID and ePedigree can help with drug recall
2D barcodes do not offer a long term solution
There are a number of significant inhibitors holding the RFID market back
A number of pharma companies have a lack of confidence in RFID
RFID has yet to establish a compelling ROI
RFID is too dependent on the legislation that administrators may decide to introduce
The structure of the RFID market in pharma
Counterfeiting is a growing problem in the developing world
The US will be the dominant market, but implementations will often be global
Europe is introducing various legislation but some countries are not waiting for the EU
Customer Impact:
Pharma companies need to prepare for the introduction of a variety of legislation
The delay in the Californian legislation means that pharma companies will not miss the deadline
Preparation for the future is key
Irrespective of legislation, pharma companies should be forward thinking
Forward thinking means not shying away from innovative technology
Pharma manufacturers must not get caught up in a fight with wholesalers
Different types of companies need different policies
Not all vendors are suitable for ePedigree and RFID implementations
The complex pharma supply chain makes RFID implementations particularly challenging
Supply chains differ considerably across the markets
The landscape of future implementations is hard to judge
Vendors need to think carefully about their five year plan
Pharma manufacturers should seek to work with all stakeholders along the supply chain
The development of standards will prove crucial for future success
Competitive Landscape
Accenture
Positioning
Alien Technology
Positioning
Blue Vector
Positioning
Hewlett Packard Company
Positioning
SAP
Positioning
What does the future hold?
Go to Market
Vendors must not fall into the trap of becoming a solution looking for a problem
A deep knowledge of life sciences is key to prevent this
Vendors need to concentrate on bringing ePedigree and RFID to the wider market
An understanding of the different needs in each market is imperative
Well developed partnerships are crucial in order for ePedigree to succeed
Flexibility also remains important
APPENDIX
Definitions
Methodology
Further reading
Ask the analyst
Datamonitor consulting
Disclaimer
List of Figures
Figure 1: US pharmaceutical supply chain
Figure 2: UK pharmaceutical supply chain
Figure 3: Accenture SWOT analysis
Figure 4: Alien Technology SWOT analysis
Figure 5: Blue Vector SWOT analysis
Figure 6: Hewlett-Packard SWOT analysis
Figure 7: SAP SWOT analysis


Abstract

Introduction

The pharmaceutical industry is facing increasing pressures to introduce ePedigree and RFID solutions into their supply chains. This will create a number of opportunities for vendors to develop their business in the area, though it will prove very challenging.

Scope
  • Counterfeiting is an increasing problem for the pharmaceutical industry
  • Legislation could be key to the success of ePedigree and RFID
  • Implementations of ePedigree and RFID will not be simple
  • Geographic differences add an extra layer of complexity
Highlights

RFID has been a hyped solution in the pharmaceutical industry for a number of years. This report assesses the drivers and inhibitors behind ePedigree and RFID and the strategy vendors need to adopt to achieve success.

Reasons to Purchase
  • Understand the challenges facing pharma companies and how counterfeit drugs are effecting their business
  • Learn what makes vendors competitive who in the market is well positioned



Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008